Bullish Moving Averages
1
Bearish Moving Averages
15
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
326.20Today’s High
349.8052W low
273.6052W High
514.80Open Price
341.10Prev. Close
328.4000Volume
28403.00Value
9395712.40Fundamentals
Market Cap Cr
875.20
Price to Earnings
39.00
Price to Book Value
4.70
Dividend Yield
1.50
PE to Growth
-5.50
Op Revenue TTM Cr
208.70
Net Profit TTM Cr
22.46
Cash From Operating Activity Cr
35.17
Return on Equity %
11.98
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
74.8
Week
68.7
Month
68.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
338.83
PIVOT
First Resistance
343.32
Second Resistance
346.48
Third Resistance
350.97
First Support
335.67
Second Support
331.18
Third Support
328.02
Relative Strength Index
53.19
Money Flow Index
54.42
MACD
1.36
MACD Signal
1.6
Average True Range
10.82
Average Directional Index
21.47
Rate of Change (21)
4.69
Rate of Change (125)
-13.63
Commodity Channel Index
18.4
Williams %R
-44.5
BETA
1 Month
1.2
3 Month
1.07
1 Year
0.81
3 Year
0.39
PRICE CHANGE ANALYSIS
↓ -2.86%
1 Week
Low
High
326.2
349.8
↑ 1.82%
1 Month
Low
High
275
349.8
↑ 8.96%
3 Months
Low
High
275
375.5
↓ -17.32%
6 Months
Low
High
273.6
405.05
↓ -11.12%
1 Year
Low
High
273.6
514.85
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 45.97 | 49.76 | 60.10 | 62.15 | 58.01 | 61.88 | 61.65 | 60.91 | 52.41 | 56.43 | 59.77 | |
| Operating Expenses Qtr | 40.82 | 43.84 | 49.46 | 51.52 | 50.01 | 51.51 | 47.62 | 54.18 | 51.51 | 48.86 | 49.21 | |
| Operating Profit Qtr | 2.67 | 3.40 | 8.37 | 8.64 | 5.44 | 8.63 | 12.90 | 6.42 | 0.63 | 5.61 | 10.28 | |
| EBIDT Qtr Cr | 5.16 | 5.92 | 10.64 | 10.63 | 8.00 | 10.37 | 14.02 | 0.93 | 0.90 | 7.56 | 10.57 | |
| Depreciation Qtr | 0.40 | 0.41 | 0.46 | 0.39 | 0.48 | 0.33 | 0.20 | 0.19 | 0.65 | 0.37 | 0.23 | |
| Net Profit Qtr | 3.55 | 3.96 | 7.47 | 7.48 | 5.60 | 7.78 | 10.41 | 0.37 | 0.03 | 5.41 | 7.31 | |
| Basic EPS Qtr | 1.31 | 1.48 | 2.84 | 2.85 | 2.14 | 2.97 | 3.97 | 0.14 | 0.01 | 2.06 | 2.79 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 217.98 | 242.45 | 229.43 | 192.34 | 161.09 | |
| Operating Expenses Annual Cr | 185.63 | 202.56 | 200.30 | 168.87 | 150.04 | |
| Operating Profit Annual | 23.07 | 34.15 | 25.79 | 19.08 | 8.53 | |
| Operating Profit Margin Annual % | 10.58 | 14.09 | 11.24 | 9.92 | 5.30 | |
| Total Expenses Annual Cr | 188.11 | 204.18 | 202.11 | 170.47 | 151.68 | |
| EBIDT Annual Cr | 32.35 | 39.88 | 29.13 | 23.47 | 11.06 | |
| EBIDT Annual margin % | 14.84 | 16.45 | 12.70 | 12.20 | 6.86 | |
| Depreciation | 1.66 | 1.21 | 1.53 | 0.51 | 1.13 | |
| PAT Before ExtraOrdinary Items Annual Cr | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 | |
| Net Profit Annual | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 | |
| Basic EPS Annual | 8.49 | 10.20 | 7.48 | 6.51 | 3.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 187.40 | 158.89 | 130.86 | 121.93 | 111.03 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 10.55 | 8.48 | 3.44 | 1.88 | 3.09 | |
| Total Current Liabilities Annual Cr | 19.13 | 27.57 | 34.16 | 40.40 | 32.83 | |
| Total Capital Plus Liabilities Annual Cr | 217.08 | 194.95 | 168.45 | 164.20 | 146.95 | |
| Fixed Assets Annual | 9.30 | 24.28 | 24.75 | 25.72 | 26.34 | |
| Total Non Current Assets Annual | 17.82 | 30.39 | 57.68 | 43.73 | 52.04 | |
| Total Current Assets Annual | 199.25 | 164.56 | 110.78 | 120.48 | 94.91 | |
| Total Assets Annual | 217.08 | 194.95 | 168.45 | 164.20 | 146.95 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 6.09 | 5.87 | 5.99 | 6.06 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 35.17 | 46.66 | 5.60 | 28.22 | 11.25 | |
| Cash from Investing Activity Annual | -24.55 | -57.67 | -26.21 | -2.26 | -10.76 | |
| Cash from Financing Annual Activity | -8.91 | -0.46 | -12.30 | -6.83 | -0.94 | |
| Net Cash Flow Annual | - | -11.47 | -32.91 | 19.13 | -0.46 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 70.88 | 60.65 | 46.96 | 43.55 | 39.39 | |
| ROE Annual % | 11.98 | 16.81 | 15.92 | 14.95 | 7.62 | |
| ROCE Annual % | 15.50 | 23.10 | 20.55 | 18.54 | 8.69 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.06 | 0.05 | |
| EBDIT Annual Margin % | 15.49 | 16.84 | 12.88 | 12.48 | 6.97 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| MUKUL MAHAVIR AGRAWAL | 1.75 | 75070177 | - | - |
| LINCOLN P COELHO | 1.17 | 75070179 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| RAJPAL SINGH KOCHHAR | 4.58 | 75070158 | 0 | 0 |
| INFINITY HOLDINGS | 25.01 | 75070162 | 0 | 0 |
| ARESKO PROGRESSIVE PRIVATE LIMITED | 20.18 | 75070160 | 0 | 0 |
| INFINITY HOLDINGS SIDECAR I | 17.99 | 75070163 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| MUKUL MAHAVIR AGRAWAL | 1.75 | 75070177 |
| SANJIV KUMAR DUDEJA | 1.4 | 75070178 |
| LINCOLN P COELHO | 1.17 | 75070179 |
| HUF | 1 | 75070171 |
| AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED | 1.46 | 75070174 |
| Manish Gupta | 1.92 | 75070182 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 21, 2023 | 5 | FINAL | Aug 21, 2023 | Equity Share |
| Oct 29, 2021 | 4 | INTERIM | Nov 01, 2021 | Equity Share |
| Sep 22, 2021 | 1 | FINAL | - | Equity Share |
| Sep 22, 2020 | 0.5 | FINAL | - | Equity Share |
| Sep 20, 2019 | 0.25 | FINAL | - | Equity Share |
| Sep 18, 2018 | 0.1 | FINAL | - | Equity Share |
| Sep 21, 2017 | 0.1 | FINAL | - | Equity Share |
| Sep 21, 2016 | 0.1 | FINAL | - | Equity Share |
| Sep 21, 2015 | 0.1 | FINAL | - | Equity Share |
| Sep 25, 2014 | 0.5 | FINAL | - | Equity Share |
| Sep 25, 2013 | 0.5 | FINAL | - | Equity Share |
| Sep 21, 2012 | 0.5 | FINAL | - | Equity Share |
| Sep 23, 2011 | 0.5 | FINAL | - | Equity Share |
| Sep 21, 2010 | 0.5 | FINAL | - | Equity Share |
| Sep 23, 2009 | 0.25 | FINAL | - | Equity Share |
| Sep 24, 2008 | 0.1 | FINAL | - | Equity Share |
| Sep 21, 2007 | 0.1 | FINAL | - | Equity Share |
| Sep 26, 2006 | 0.1 | FINAL | - | Equity Share |
| Sep 26, 2005 | 1 | FINAL | - | Equity Share |
| Aug 27, 2004 | 0.5 | FINAL | - | Equity Share |
| May 30, 2003 | 3.75 | FINAL | - | Equity Share |
| Mar 05, 2002 | - | FINAL | - | Equity Share |
| Sep 11, 2001 | - | FINAL | - | Equity Share |
| Sep 06, 2000 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Jul 20, 2004 | 10:5 | 2004-07-28 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 20, 2024 | Audited Results & Final Dividend | - |
| Feb 02, 2024 | Quarterly Results | - |
| Nov 03, 2023 | Quarterly Results | - |
| Aug 02, 2023 | Quarterly Results | - |
| May 23, 2023 | Audited Results & Dividend | - |
| Feb 08, 2023 | Quarterly Results | - |
| Nov 09, 2022 | Quarterly Results | - |
| Aug 09, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited & Quarterly Results | - |
| May 13, 2022 | Others | - |
| Feb 11, 2022 | Quarterly Results | (Revised) |
| Oct 19, 2021 | Quarterly Results & Interim Dividend | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 30, 2021 | Audited Results & Dividend | - |
| May 25, 2021 | Others | Inter alia, to consider and approve investment in the associate company along with other routine matters. |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Jul 29, 2020 | Audited Results & Dividend | - |
| Feb 13, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 28, 2019 | Audited Results, Final Dividend & A.G.M. | - |
| Feb 13, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 09, 2018 | Audited Results & Dividend | - |
| May 30, 2018 | Audited Results & Dividend | - |
| Feb 09, 2018 | Quarterly Results | - |
| Dec 12, 2017 | Quarterly Results | - |
| Aug 14, 2017 | Quarterly Results | - |
| May 28, 2017 | Audited Results & Dividend | - |
| Feb 14, 2017 | Quarterly Results | - |
| Nov 11, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results & Dividend | - |
| Feb 17, 2016 | Others | To consider and approve the notice and date for Extra Ordinary General Meeting of the Company. |
| Jan 25, 2016 | Others | To explore opportunities, in connection with optimum utilization of Company's assets and analyze the cost comparison / utilization of funds by alternate means. |
| Nov 10, 2015 | Quarterly Results | - |
| Aug 13, 2015 | Quarterly Results | - |
| May 29, 2015 | Audited Results & Dividend | - |
| Feb 13, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 21, 2014 | Quarterly Results | - |
| May 30, 2014 | Audited Results & Dividend | - |
| Feb 13, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Aug 14, 2013 | Quarterly Results | - |
| May 30, 2013 | Audited Results & Dividend | - |
| Feb 13, 2013 | Quarterly Results | - |
| Nov 10, 2012 | Quarterly Results | - |
| Aug 13, 2012 | Quarterly Results | - |
| May 30, 2012 | Audited Results & Dividend | - |
| Feb 13, 2012 | Quarterly Results | - |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 12, 2011 | Audited, Quarterly Results & Dividend | - |
| May 13, 2011 | Quarterly Results | - |
| Feb 11, 2011 | Quarterly Results | - |
| Nov 13, 2010 | Quarterly Results | - |
| Aug 13, 2010 | Audited, Quarterly Results & Dividend | For the quarter ended 30.06.2010. |
| May 13, 2010 | Quarterly Results | - |
| Jan 30, 2010 | Quarterly Results | - |
| Oct 29, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results & Dividend | - |
| Jan 28, 2009 | Quarterly Results | - |
| Oct 31, 2008 | Quarterly Results | - |
| Sep 01, 2008 | Audited Results & Dividend | - |
| Jul 29, 2008 | Quarterly Results | - |
| Apr 30, 2008 | Quarterly Results | - |
| Jan 31, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Aug 25, 2007 | Audited Results & Dividend | - |
| Jul 28, 2007 | Quarterly Results | - |
| Apr 30, 2007 | Quarterly Results | - |
| Jan 30, 2007 | Quarterly Results | (Revised) |
| Oct 30, 2006 | Quarterly Results | - |
| Jul 31, 2006 | Quarterly Results | - |
| Jun 14, 2006 | Accounts & Dividend | - |
| Jan 28, 2006 | Quarterly Results | - |
| Oct 26, 2005 | Quarterly Results | - |
| Aug 23, 2005 | Dividend | - |
| Jul 30, 2005 | Quarterly Results | - |
| Apr 30, 2005 | Quarterly Results | - |
| Jan 27, 2005 | Quarterly Results | - |
| Oct 30, 2004 | Quarterly Results | - |
| Jul 15, 2004 | Quarterly Results & Dividend | - |
| Apr 30, 2004 | Quarterly Results, Bonus & Stock Split | Sub Division of Equity shares |
| Jan 31, 2004 | Quarterly Results | - |
| Oct 30, 2003 | Quarterly Results | - |
| Jul 29, 2003 | Quarterly Results | - |
| Apr 30, 2003 | Quarterly Results | - |
| Mar 05, 2003 | Quarterly Results & Dividend | (Revised) |
| Oct 31, 2002 | Quarterly Results | - |
| Jul 31, 2002 | Quarterly Results | - |
| Apr 29, 2002 | Quarterly Results | - |
| Jan 30, 2002 | Quarterly Results | - |
| Dec 27, 2001 | Accounts | - |
| Oct 31, 2001 | Quarterly Results | - |
| Jul 30, 2001 | Quarterly Results | - |
| Jun 21, 2001 | Accounts, Dividend & Quarterly Results | - |
| Jan 30, 2001 | Quarterly Results | - |
| Oct 31, 2000 | Quarterly Results | - |
| Jul 28, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Accounts & dividend | - |
| Jan 28, 2000 | Quarterly Results | - |
| Jul 31, 1999 | Quarterly Results | - |
| May 28, 1999 | Accounts | - |
| Apr 29, 1999 | Quarterly Results (Cancelled) | - |
| Apr 28, 1999 | Quarterly Results | - |
| Jan 06, 1999 | Issue of equity shares on Prefer. Basis | - |
| Oct 30, 1998 | Quarterly Results | - |
| Jul 28, 1998 | Quaterly Results | - |
| Jun 10, 1998 | Accounts & Dividend | - |
| Jun 28, 1997 | Annual Accounts & Dividend. | - |
| Mar 31, 1997 | Half Yearly Results. & Public Issue | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jul 20, 2004 | 3:1 | 2004-07-28 |
28 Jun 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & Immediate relative of Designated Persons, Trading for dealing in securities of Jagsonpal Pharmaceuticals Limited shall remain closed with effect from Monday, July 01, 2024 till the end of 48 hours after the declaration of Unaudited financial results for quarter ended June 30, 2024.
20 Jun 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We are Pleased to informed you that the Nomination and Remuneration Committee has issued and allotted 16,317 Equity shares of Rs. 5/- each under JPL ESOP 2022, to the eligible employee of the company.
31 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We now wish to inform you that on completion of customary conditions, the transactions has now achieved as closure.
24 May 2024
Jagsonpal Pharma introduces new product; shares rise
The shares were up by 4.71 per cent to 349 at 12 pm on the BSE
24 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith copy of press release isuued by the company titled " Jagsonpal Launched MemUp: India''s First Biodentical Hormone Replacement Therapy in a Single Pill"
22 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of advertisement published on May 22, 2024, in ''Business Standard'' (English) and ''Business Standard'' (Hindi) newspaper providing Extract of Audited Financial Results of the Company for the quarter and year ended March 31, 2024.
21 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024.
20 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed related party disclosure for the half year ended October 01, 2023 to March 31, 2024
20 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of grant of Employee Stock Options
20 May 2024
JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Corporate Action-Board to consider Dividend
The Board of Directors at their meeting held today have recommended dividend of Rs. 5/- (100%) per equity share of face value of Rs. 5/- for the financial year ended March 31, 2024.
